News Room - Press Releases and Articles (2004)

 

Christian Valcke, Ph.D., Appointed as Nanomix Vice President of Research & Development

Emeryville, CA. - September 7, 2004 - Nanomix, Incorporated, today confirmed the appointment of Christian Valcke, Ph.D., as Vice President of Research and Development to lead the company's research and development activities and product commercialization agenda. In this position, Dr. Valcke will report to David Macdonald, President and CEO of Nanomix.

Dr. Valcke has over 17 years experience in commercial research and development including many projects related to FDA regulated diagnostic and drug delivery systems. Born in Belgium, Dr. Valcke obtained his undergraduate degree at the Katholieke Universiteit Leuven. His professional preparation continued with M.S. in Systems Sciences and Ph.D. in Electrical Engineering degrees from the University of California, Los Angeles. He also completed a postdoctoral program in Anesthesiology and an executive management program at UCSD. Dr. Valcke holds a number of publications, patents and awards.

His early career was spent developing a closed-loop drug delivery system for pharmacological stress testing. Dr. Valcke’s most recent appointment was as Vice President of Systems Development at Nanogen in San Diego, CA. Prior to this he served as the Director of Biomedical Development, Gensia Automedics in San Diego, CA.

"Chris Valcke is a valuable addition to our team at Nanomix," said David Macdonald. "The combination of his academic training and business experience are an excellent match for Nanomix. Chris brings a tremendous set of scientific, leadership and business skills that are critical as we move the company into product development and commercialization".